Emerging reports suggest venous and arterial thromboembolic diseases can complicate recovery from COVID-19. Postulated mechanisms include hypercoagulability, hypoxia, immobilisation, excessive inflammation and diffuse intravascular coagulation, especially in patients with severe COVID-19 infection. Nauka et al. provided vital insight that thrombotic complications can happen in a patient with non-critically ill COVID-19 infection. They reported a case of deep venous thrombosis (DVT) in a patient with mild COVID-19 infection and was treated with apixaban.
This article is available only as a PDF. Please click on “Download PDF” to view the full article.
